-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Longboard Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Longboard Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.81M, a 234% increase year-over-year.
- Longboard Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $6.27M, a 114% increase year-over-year.
- Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.25M, a 22.5% increase from 2022.
- Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.66M, a 35.1% increase from 2021.
- Longboard Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.97M, a 76.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)